Superantigens: Microbial agents that corrupt immunity

Lancet Infectious Diseases

Volumn 2, Issue 3, 2002, Pages 156-162

  Llewelyn, Martin ^a   Cohen, Jon ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STAPHYLOCOCCUS ENTEROTOXIN; SUPERANTIGEN; TOXIC SHOCK SYNDROME TOXIN 1;

GRAM NEGATIVE BACTERIUM; IMMUNITY; MYCOPLASMA; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE ACTIVATION; TOXIC SHOCK SYNDROME; VIRUS;

EID: 0036234708     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(02)00222-0     Document Type: Review

References (62)

1. The staphylococcal enterotoxins and their relatives
2. Selective expansion of T-cells expressing Vβ2 in toxic shock syndrome
3. Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor V beta specificity
4. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen
5. Bacterial superantigens in human disease: Structure, function and diversity
6. The structural basis of T cell activation by superantigens
7. Signal transduction by microbial superantigens via MHC class II molecules
8. T cell-mediated lethal shock triggered in mice by the superantigen staphytococcal enterotoxin B: Critical role of tumor necrosis factor
9. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B
10. Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins
11. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity
12. Programmed cell death and extrathymic reduction of Vbeta8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B
13. Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C
14. Structure and function of streptococcal and staphylococcal superantigens in septic shock
15. Relationship between enterotoxic- and T lymphocyte-stimulating activity of staphylococcal enterotoxin B
16. Staphylococcal enterotoxins
17. Induction of acute inflammation in vivo by staphylococcal superantigens I: Leukocyte recruitment occurs independently of T lymphocytes and major histocompatibility complex class II molecules
18. Molecular analysis of the role of streptococcal pyrogenic exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes
19. Toxic shock syndrome and bacterial superantigens: An update
20. Toxic shock syndrome surveillance in the United States, 1980 to 1981
21. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition
22. Invasive group A streptococcus infections
23. The toxic shock syndromes
24. Invasive group A streptococcal disease in children and association with varicella zoster virus infection
25. Group A streptococci in the 1990s
26. Toxic shock syndrome in the United States: Surveillance update, 1979-1996
27. Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen
28. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin -neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome
29. Structure-function studies of T-cell receptor-superantigen interactions
30. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome
31. Report of the National Institutes of Health Workshop on Kawasaki Disease
32. Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals
33. Transcytosis of staphylococcal superantigen toxins
34. Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents
35. Identification and characterization of novel superantigens from Streptococcus pyogenes
36. The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and significant antigenic variation
37. Immunogenetic and biological aspects of in vitro lymphocyte allotransformation (MLR) in the mouse
38. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen
39. Mycoplasma superantigen is a CDR3-dependent ligand for the T cell antigen receptor
40. Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes
41. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection
42. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production
43. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - A comparative observational study
44. Intravenous immunoglobulin for treating sepsis and septic shock (Cochrane Review)
45. Inhibition of bacterial superantigens by peptides and antibodies
46. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation
47. Exotoxins of Staphylococcus aureus
48. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A
49. Characerization of a superantigen produced by Yersinia pseudotuberculosis
50. Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors V beta 6.9 and V beta 22
51. The sequence of the Mycoplasma arthritidis superantigen, MAM: Identification of functional domains and comparison with microbial superantigens and plant lectin mitogens
52. Anti-MAM antibodies in rheumatic disease: Evidence for a MAM-like superantigen in rheumatoid arthritis?
53. Recombinant Staphylococcus aureus exfoliative toxins are not bacterial superantigens
54. Reactivity of mouse T-cell hybridomas expressing human Vbeta gene segments with staphylococcal and streptococcal superantigens
55. Nothing in biology makes sense except in the light of evolution
56. High-frequency intracellular infection and erythrogenic toxin A expression undergo phase variation in M1 group A streptococci
57. Complete genome sequence of an M1 strain of Streptococcus pyogenes
58. Streptococcal toxic shock like syndrome; evidence of superantigen activity and its effects on T lymphocyte subsets in vitro
59. Selective Depletion of Vβ-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome
60. Superantigens in human disease
61. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response
62. Understanding the mechanism of action of bacterial superantigens from a decade of research